Clinical trial
An Exploratory Multicenter, Double-Blind, Diphenhydramine- and Placebo-Controlled Safety, Efficacy and Biomarker Study With JNJ-42847922 in Subjects With Major Depressive Disorder
NCT02476058 is registered in ClinicalTrials.gov with Janssen-Cilag International NV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Multicenter, Double-Blind, Diphenhydramine- and Placebo-Controlled Safety, Efficacy and Biomarker Study With JNJ-42847922 in Subjects With Major Depressive Disorder
- Lead sponsor
- Janssen-Cilag International NV
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 11, 2015
- Completion date
- January 4, 2016
- Enrollment
- 48 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.